Market Place
Sourcing Support
Fosun Attends CIIE, Confident in China’s Open Market Opportunity
07 Nov 2024 //
PR NEWSWIRE
Gilead`s Kite Exits China Joint Venture With Fosun
19 Sep 2024 //
FIERCE PHARMA
Fosun Pharma Announces 2024 Interim Results
28 Aug 2024 //
PR NEWSWIRE
Diplomatic Envoys To China Visit Fosun For Business Cooperation Opportunities
18 Jun 2024 //
PR NEWSWIRE
Guo Guangchang: Fosun Steadfastly Focuses on Innovation + Globalization
23 May 2024 //
PR NEWSWIRE
Fosun International Earns a Spot on "2024 Fortune China ESG Impact List"
15 May 2024 //
PR NEWSWIRE
Fosun Pharma`s Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention
26 Apr 2024 //
PR NEWSWIRE
Fosun`s Artemisinin Meds Boost Malaria Prevention in Africa
26 Apr 2024 //
PR NEWSWIRE
Fosun`s PIII Trial Project forAntimalarial Drug Receives 500M Investment
14 Dec 2023 //
PR NEWSWIRE
Fosun Pharma Announces Its Attendance at the 42nd Annual J.P. Morgan Conference
11 Dec 2023 //
PR NEWSWIRE
Fosun Pharma USA Announces Abstract to be Presented at IASLC 2023
28 Nov 2023 //
PR NEWSWIRE
Palatin`s Vyleesi® Licensee Fosun Pharma Reports First Commercial Sale in China
08 Aug 2023 //
PR NEWSWIRE
Fosun Pharma to receive $100M+ via World Bank for facility in Ivory Coast
07 Jun 2023 //
ENDPTS
Fosun and IFC Partner to Improve Access to High Quality Medicines in Africa
06 Jun 2023 //
PR NEWSWIRE
Fosun Pharma to build African manufacturing plant with IFC help
06 Jun 2023 //
FIERCE PHARMA
Fosun Pharma Announces its 15th Corporate Social Responsibility Report
29 Mar 2023 //
PR NEWSWIRE
Fosun Pharma, Genuine Biotech to up output of COVID drug Azvudine with companies
20 Jan 2023 //
REUTERS
Fosun, Genuine Biotech will donate COVID treatment Azvudine to China
09 Jan 2023 //
REUTERS
Fosun Pharma and Henlius Entered into an Agreement for Serplulimab in the US
07 Jan 2023 //
PR NEWSWIRE
Henlius & Fosun Pharma Entered into License Agreement for HANSIZHUANG in the US
28 Dec 2022 //
PRESS RELEASE
BioNTech and Fosun Pharma Announce Full Regulatory Approval
23 Dec 2022 //
PRESS RELEASE
BioNTech and Fosun Pharma Provide COVID-19 Vaccine Doses For Vaccinatio
21 Dec 2022 //
GLOBENEWSWIRE
Fosun taps big buyout funds for Gland Pharma
14 Dec 2022 //
ECONOMIC TIMES
Fosun taps big buyout funds for Gland Pharma
13 Dec 2022 //
ECONOMIC TIMES
Fosun said to mull sale of $3.6 Billion Gland Pharma
30 Nov 2022 //
ECONOMIC TIMES
BioNTech and Fosun Pharma Receive EUA for Omicron-BA.4/BA.5 Bivalent Vaccine
11 Nov 2022 //
PRESS RELEASE
Fosun Participates in the CIIE for the Fifth Consecutive Year
04 Nov 2022 //
PRNEWSWIRE
Fosun Pharma`s MSCI ESG Rating Upgraded to A
13 Oct 2022 //
PRNEWSWIRE
Fosun`s Businesses Shows Strong Recovery Momentum
30 Jun 2022 //
PRNEWSWIRE
Fosun, Amgen collaborate to bring two innovative medicines to Chinese patients
29 Jun 2022 //
BIOSPECTRUMASIA
Amgen takes next step with China ambitions, out-licensing drugs to Fosun Pharma
27 Jun 2022 //
ENDPTS
Fosun International`s FTSE Russell ESG Rating Upgraded
23 Jun 2022 //
PRNEWSWIRE
VerImmune and Fosun Pharma focus on virus-inspired particle
23 May 2022 //
BIOSPECTRUMASIA
Fosun Pharma 2021 Annual Results Announcement
22 Mar 2022 //
PRNEWSWIRE
Chinese-owned Gland Pharma re-appoints Srinivas Sadu as MD & CEO
10 Mar 2022 //
ECONOMIC TIMES
Fosun Pharma and Insilico team up in AI discovery deal
11 Jan 2022 //
ENDPTS
China`s Fosun inks $628M deal for a Prevnar 13 rival
28 Oct 2021 //
ENDPTS
Inhibrx shares rise on PhI trial results; Braglia`s Helsinn partners with Fosun
12 Oct 2021 //
ENDPTS
Helsinn and Fosun Pharma sign exclusive license and distribution agreements
12 Oct 2021 //
GLOBENEWSWIRE
Fosun Pharma Announces 2021 Interim Results
24 Aug 2021 //
PRNEWSWIRE
Kintor collaborate Fosun Pharma to commercialise proxalutamide
19 Jul 2021 //
PHARMABIZ
Hong Kong says no personal data shared in vaccine deal with Fosun
14 Jul 2021 //
REUTERS
Production line of mRNA vaccine expected to be completed by August
14 Jun 2021 //
GLOBAL TIMES
BioNTech, Fosun eye 1B doses of COVID-19 vaccine capacity with new China JV
11 May 2021 //
FIERCE PHARMA
Revance Announces First Patient Enrolled for DaxibotulinumtoxinA
27 Apr 2021 //
BUSINESSWIRE
Fosun submits trial data of foreign COVID-19 vaccine for state review: source
19 Apr 2021 //
GLOBALTIMES
BioNTech and Fosun Receive Authorization for Emergency Use in Hong Kong
25 Jan 2021 //
PRNEWSWIRE
BioNTech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong
25 Jan 2021 //
PRNEWSWIRE
China`s Fosun plans plant to make BioNTech`s COVID-19 vaccine -Caixin
04 Jan 2021 //
REUTERS
China`s Fosun plans plant to make BioNTech`s COVID-19 vaccine -Caixin
30 Dec 2020 //
REUTERS
Fosun Pharma to buy 100M doses of BioNTech`s COVID-19 vaccine
16 Dec 2020 //
REUTERS
BioNTech, Fosun start Phase II trial of COVID-19 vaccine in China
25 Nov 2020 //
REUTERS
China approves Shanghai Fosun`s unit to run human testing for BioNTech`s
13 Nov 2020 //
REUTERS
China’s Fosun Kicks Off Biggest Pharma IPO in India
06 Nov 2020 //
BLOOMBERG
World Health Assembly charts course for COVID-19 response and global health
05 Nov 2020 //
WHO
China`s Fosun to seek approval for BioNTech`s COVID-19 second vaccine
05 Nov 2020 //
REUTERS
Fosun follows BioNTech in changing COVID-19 vaccine
04 Nov 2020 //
FIERCE BIOTECH
China`s Fosun to end BioNTech`s COVID-19 vaccine trial, seek approval
03 Nov 2020 //
REUTERS
Eli Lilly Licenses Blood Disorder Drug From Fosun for $40M
30 Oct 2020 //
BLOOMBERGLAW
Vaccines’ impact on pandemic could come as early as April, says boss of Fosun
21 Oct 2020 //
SCMP
